Breast Cancer Clinical Trials in Chengdu, Sichuan
7 recruitingChengdu, Sichuan, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)
Breast Cancer
Fudan University764 enrolled15 locationsNCT05909332
Recruiting
Phase 1
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Breast CancerLung CancerSolid Tumors+1 more
Sichuan Baili Pharmaceutical Co., Ltd.22 enrolled1 locationNCT07274852
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Phase 3
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Breast Cancer
Laekna Limited256 enrolled55 locationsNCT04851613
Recruiting
Not Applicable
Neoadjuvant Chemoradiotherapy Compared to Neoadjuvant Chemotherapy for Luminal-Type Locally Advanced Breast Cancer: a Clinical Study
Breast Cancer
Sichuan Cancer Hospital and Research Institute148 enrolled1 locationNCT06697938
Recruiting
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Breast Cancer
First Hospital of China Medical University600 enrolled5 locationsNCT06282796
Recruiting
Phase 3
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Breast Cancer
Fudan University766 enrolled15 locationsNCT05891093